Oct. 09. 2025Topics
Driving cross-border innovation to bring advanced therapies closer to patients in the Asia-Pacific region
Teijin Regenet and Melbourne-based Cell Therapies Pty Ltd. have formed a strategic alliance to accelerate access to advanced therapies between Japan and Australia.
In an exclusive interview with BioPharma APAC, Takeshi Hosoyama, Deputy President of Teijin Regenet, shares key insights on:
- Streamlining regulatory pathways
- Enhancing GMP readiness
- Strengthening CGT ecosystem across the Asia-Pacific region
→ Read the full interview here
